Umeshita K - Search Results

1

PLOD2 induced under hypoxia is a novel prognostic factor for hepatocellular carcinoma after curative resection.

Noda T, Yamamoto H, Takemasa I, Yamada D, Uemura M, Wada H, Kobayashi S, Marubashi S, Eguchi H, Tanemura M, Umeshita K, Doki Y, Mori M, Nagano H. Noda T, et al. Among authors: umeshita k. Liver Int. 2012 Jan;32(1):110-8. doi: 10.1111/j.1478-3231.2011.02619.x. Epub 2011 Aug 11. Liver Int. 2012. PMID: 22098155

2

[The relationship between postoperative prognosis and positivity of PIVKA-II in patients with hepatocellular carcinoma].

Sakon M, Monden M, Goto M, Kanai T, Umeshita K, Ukei T, Mori T. Sakon M, et al. Among authors: umeshita k. Nihon Geka Gakkai Zasshi. 1992 Aug;93(8):827-32. Nihon Geka Gakkai Zasshi. 1992. PMID: 1331743 Japanese.

3

Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiple hepatic lesions.

Monden M, Sakon M, Gotoh M, Kanai T, Umeshita K, Wang KS, Sakurai M, Kuroda C, Okamura J, Mori T. Monden M, et al. Among authors: umeshita k. Cancer Chemother Pharmacol. 1992;31 Suppl:S38-44. doi: 10.1007/BF00687103. Cancer Chemother Pharmacol. 1992. PMID: 1333907

4

Relationship between pathologic prognostic factors and abnormal levels of des-gamma-carboxy prothrombin and alpha-fetoprotein in hepatocellular carcinoma.

Sakon M, Monden M, Gotoh M, Kanai T, Umeshita K, Nakano Y, Mori T, Sakurai M, Wakasa K. Sakon M, et al. Among authors: umeshita k. Am J Surg. 1992 Feb;163(2):251-6. doi: 10.1016/0002-9610(92)90111-4. Am J Surg. 1992. PMID: 1371207

5

Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinomas.

Monden M, Okamura J, Sakon M, Gotoh M, Kobayashi K, Umeshita K, Yamada T, Kuroda C, Sakurai M, Mori T. Monden M, et al. Among authors: umeshita k. Cancer Chemother Pharmacol. 1989;23 Suppl:S90-5. doi: 10.1007/BF00647249. Cancer Chemother Pharmacol. 1989. PMID: 2538272

6

Nonvascularized islet xenograft rejection in a mouse-to-rat combination where the vascularized heart is rapidly rejected.

Fukuzaki T, Gotoh M, Hasuike Y, Tanigawa T, Nagano H, Umeshita K, Kanai T, Monden M, Mori T. Fukuzaki T, et al. Among authors: umeshita k. Transplant Proc. 1994 Apr;26(2):779. Transplant Proc. 1994. PMID: 7513472 No abstract available.

7

The prognostic significance of macroscopic growth pattern of hepatocellular carcinoma.

Sakon M, Monden M, Umeshita K, Gotoh M, Kanai T, Mori T, Okamura J. Sakon M, et al. Among authors: umeshita k. Int Surg. 1994 Jan-Mar;79(1):38-42. Int Surg. 1994. PMID: 8063553

8

New development of transarterial immunoembolization (TIE) for therapy of hepatocellular carcinoma with intrahepatic metastases.

Kanai T, Monden M, Sakon M, Gotoh M, Umeshita K, Hasuike Y, Nakano H, Monden T, Murakami T, Nakamura H, et al. Kanai T, et al. Among authors: umeshita k. Cancer Chemother Pharmacol. 1994;33 Suppl:S48-54. doi: 10.1007/BF00686668. Cancer Chemother Pharmacol. 1994. PMID: 8137485

9

Hilar lobar vascular occlusion for hepatic resection.

Gotoh M, Monden M, Sakon M, Kanai T, Umeshita K, Nagano H, Mori T. Gotoh M, et al. Among authors: umeshita k. J Am Coll Surg. 1994 Jan;178(1):6-10. J Am Coll Surg. 1994. PMID: 8156120

10

[Well-differentiated hepatocellular carcinoma].

Umeshita K, Sakon M, Hasuike Y, Kanai T, Gotoh M, Monden M, Wakasa K, Sakurai M. Umeshita K, et al. Ryoikibetsu Shokogun Shirizu. 1995;(7):470-2. Ryoikibetsu Shokogun Shirizu. 1995. PMID: 8749528 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

392 results

Search Page

Filters